Alvotech ALVO
NASDAQ ALVO
$5.21 +0.02 (+0.38%)
As of: Sep 9, 2026 · 3:59 PM EDT

Alvotech (ALVO) Current Deferred Revenue (2020 - 2026)

Alvotech's (ALVO) quarterly Current Deferred Revenue came in at $4.2 million in Q2 2026, down 67.66% on a YoY basis from $12.9 million in Q2 2025, and down 68.18% quarter-over-quarter from $13.1 million in Q1 2026.

Analysis

Alvotech (ALVO) Current Deferred Revenue (2020 - 2026) Analysis & Trends

Alvotech (ALVO) has reported Current Deferred Revenue for 7 consecutive years, with $4.2 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Current Deferred Revenue fell 67.66% year-over-year to $4.2 million; the trailing twelve-month figure through Jun 2026 stood at $4.2 million (down 67.66% YoY), and the FY2025 full-year result was $5.5 million, down 93.19% from the prior year.
  • Current Deferred Revenue declined to $4.2 million in Q2 2026 per ALVO's latest filing, from $13.1 million in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $90.1 million in Q2 2024 and bottomed at $4.2 million in Q2 2026.
  • Historically, Current Deferred Revenue has averaged $54.3 million across 5 years, with a median of $65.3 million in 2023.
  • The sharpest annual moves came in 2023 and 2025: Current Deferred Revenue surged 91.4% in 2023, then sank 93.19% in 2025.
  • Over 5 years, Current Deferred Revenue stood at $57.0 million in 2022, then climbed by 28.49% to $73.3 million in 2023, then advanced by 10.18% to $80.7 million in 2024, then tumbled by 93.19% to $5.5 million in 2025, then retreated by 24.05% to $4.2 million in 2026.
  • According to Business Quant data, Current Deferred Revenue over the past three periods registered $4.2 million, $13.1 million, and $5.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 42.34 Bn 38.68 Bn 2.15 Bn
2 Viatris 19.39 Bn 18.50 Bn 1.46 Bn
3 Dr Reddys Laboratories 9.99 Bn 9.85 Bn 396.53 Mn
4 Amneal Pharmaceuticals 5.57 Bn 5.53 Bn 334.51 Mn
5 Bausch Health Companies 2.45 Bn 1.58 Bn 2.10 Bn
6 Ani Pharmaceuticals 1.70 Bn 1.34 Bn 165.89 Mn
7 Alvotech 1.66 Bn 1.52 Bn 2.56 Mn
8 Amphastar Pharmaceuticals 985.90 Mn 695.77 Mn 93.47 Mn
9 Fennec Pharmaceuticals 434.07 Mn 392.82 Mn 17.15 Mn
10 NutriBand 72.57 Mn 69.15 Mn 181,874.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.18 Mn
Mar 31, 2026 13.13 Mn
Dec 31, 2025 5.50 Mn
Sep 30, 2025 80.72 Mn
Jun 30, 2025 12.91 Mn
Mar 31, 2025 80.72 Mn
Dec 31, 2024 80.72 Mn
Sep 30, 2024 85.50 Mn
Jun 30, 2024 90.12 Mn
Mar 31, 2024 88.91 Mn
Dec 31, 2023 73.26 Mn
Jun 30, 2023 57.39 Mn
Dec 31, 2022 57.02 Mn
Jun 30, 2022 29.98 Mn
Dec 31, 2021 44.84 Mn
Dec 31, 2020 38.87 Mn